Molecular Formula | C19H19ClN4O3 |
Molar Mass | 386.83216 |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
In vitro study | Wnt agonist 1 does not inhibit GSK-3β activity and may serve as a useful tool for the study of physiological processes involved in the Wnt pathway. Exposure of hCMEC/D3 cells to Wnt agonist 1 caused an increase in the proportion of cells with nuclear or perinuclear β-catenin expression (10 or 20 μm, 16 h). |
In vivo study | In the African toad model, Wnt agonist 1 (10 μm) mimics the role of Wnt in the whole organism and affects toad embryonic head differentiation. In a rat renal ischemia-reperfusion model, Wnt agonist 1 significantly reduced the plasma concentrations of creatinine, AST and LDH, and inhibited IL-6, IL-1β production and MPO activity. Wnt agonist 1 was also able to reduce renal iNOS, nitrotyrosine proteins and hydroxynonenal (4-hydroxynononenal) after renal ischemia-reperfusion, wnt agonist 1 improves kidney regeneration and its function, reducing inflammation and oxidative stress. |
biological activity | Wnt agnist 1 (BML-284 HCL, AMBMP HCL) is a cell-permeable activator of the Wnt signaling pathway, induction is dependent on the transcriptional activity of β-catenin-and TCF-with an EC50 of 0.7 μm. |
Target | Value |